The tumour microenvironment is immuno‐tolerogenic and a principal determinant of patient outcome in EBV‐positive diffuse large B‐cell lymphoma

OBJECTIVE: Epstein‐Barr virus‐positive diffuse large B‐cell lymphoma (EBV(‐pos) DLBCL) is a recently identified entity. Data regarding outcome to frontline immuno‐chemotherapy are conflicting. Although the prognostic impact of the tumour microenvironment (TME) in EBV(‐neg) DLBCL is well‐established,...

Descripción completa

Detalles Bibliográficos
Autores principales: Keane, Colm, Tobin, Joshua, Gunawardana, Jay, Francis, Santiyagu, Gifford, Grace, Gabrielli, Sara, Gill, Anthony, Stevenson, William, Talaulikar, Dipti, Gould, Clare, Jain, Sanjiv, Birch, Simone, Hertzberg, Mark, Gandhi, Maher K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899834/
https://www.ncbi.nlm.nih.gov/pubmed/31211907
http://dx.doi.org/10.1111/ejh.13274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899834/
https://www.ncbi.nlm.nih.gov/pubmed/31211907
http://dx.doi.org/10.1111/ejh.13274

Ejemplares similares